FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1979550833> ?p ?o ?g. }

• W1979550833 endingPage "441" @default.
• W1979550833 startingPage "432" @default.
• W1979550833 abstract "Summary Fabry disease is an X‐linked lysosomal storage disease caused by deficiency of α‐galactosidase A enzyme activity. Decreased enzyme activity leads to accumulation of glycosphingolipids in different tissues including endothelial cells and smooth‐muscle cells and cardiomyocytes, and cardiovascular complications are common in the disease. Since 2001, specific enzyme replacement therapy (ERT) with α‐galactosidase A has been available. It has been reported to improve clinical symptoms and quality of life. However, limited and controversial data on its efficacy to cardiac involvement have been published. Nine patients (5 male) with Fabry disease were included in an open‐label prospective follow‐up study of 24‐month ERT. Comprehensive cardiovascular evaluation was performed by MRI, stress echocardiography and quality of life assessment. Plasma globotriaosylceramide decreased from 6.2 to 1.4 μg/ml during ERT ( p <0.05). The only other measured parameters that changed significantly were resting heart rate that decreased from 79 to 67 bpm ( p <0.01) and end‐systolic volume that decreased by 12.4 ml ( p <0.05). The other parameters consisting of quality of life, self‐estimated cardiovascular condition, diastolic function, exercise capacity, ECG parameters, ejection fraction and ventricular mass did not change. ERT has only minimal effect on symptoms and cardiovascular morphology and function in Fabry disease. Therefore, effective conventional medical therapy is still of major importance in Fabry disease. Larger ERT studies are warranted, especially in women, to solve current open questions, such as the age at which ERT should be started, optimal dosage and intervals between infusions. Furthermore, longer follow‐up studies are needed to assess the effects of ERT on prognosis." @default.
• W1979550833 created "2016-06-24" @default.
• W1979550833 creator A5012093987 @default.
• W1979550833 creator A5019865568 @default.
• W1979550833 creator A5033220805 @default.
• W1979550833 creator A5033658591 @default.
• W1979550833 creator A5038203474 @default.
• W1979550833 creator A5042943293 @default.
• W1979550833 creator A5046170398 @default.
• W1979550833 creator A5064118768 @default.
• W1979550833 creator A5070124449 @default.
• W1979550833 creator A5077833691 @default.
• W1979550833 date "2008-05-23" @default.
• W1979550833 modified "2023-09-27" @default.
• W1979550833 title "Twenty‐four‐month α‐galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters" @default.
• W1979550833 cites W110796122 @default.
• W1979550833 cites W1517680595 @default.
• W1979550833 cites W1540828017 @default.
• W1979550833 cites W1604607822 @default.
• W1979550833 cites W1970036230 @default.
• W1979550833 cites W1972805683 @default.
• W1979550833 cites W1997080713 @default.
• W1979550833 cites W1997493559 @default.
• W1979550833 cites W1998207473 @default.
• W1979550833 cites W2000846576 @default.
• W1979550833 cites W2004142028 @default.
• W1979550833 cites W2011987764 @default.
• W1979550833 cites W2012420642 @default.
• W1979550833 cites W2022356406 @default.
• W1979550833 cites W2023251415 @default.
• W1979550833 cites W2029381491 @default.
• W1979550833 cites W2029848612 @default.
• W1979550833 cites W2036532718 @default.
• W1979550833 cites W2037377025 @default.
• W1979550833 cites W2038607559 @default.
• W1979550833 cites W2042609729 @default.
• W1979550833 cites W2050232726 @default.
• W1979550833 cites W2051762495 @default.
• W1979550833 cites W2053727751 @default.
• W1979550833 cites W2054960780 @default.
• W1979550833 cites W2066990527 @default.
• W1979550833 cites W2070884008 @default.
• W1979550833 cites W2071477700 @default.
• W1979550833 cites W2078287063 @default.
• W1979550833 cites W2088375877 @default.
• W1979550833 cites W2091843493 @default.
• W1979550833 cites W2093722439 @default.
• W1979550833 cites W2094557474 @default.
• W1979550833 cites W2095092277 @default.
• W1979550833 cites W2099728000 @default.
• W1979550833 cites W2105568665 @default.
• W1979550833 cites W2111207273 @default.
• W1979550833 cites W2118945535 @default.
• W1979550833 cites W2125879510 @default.
• W1979550833 cites W2132401137 @default.
• W1979550833 cites W2150921831 @default.
• W1979550833 cites W2154062927 @default.
• W1979550833 cites W2245758337 @default.
• W1979550833 cites W2313827278 @default.
• W1979550833 cites W2328023011 @default.
• W1979550833 cites W2332862830 @default.
• W1979550833 cites W2580466971 @default.
• W1979550833 cites W2990123797 @default.
• W1979550833 cites W4292806894 @default.
• W1979550833 doi "https://doi.org/10.1007/s10545-008-0848-3" @default.
• W1979550833 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18509742" @default.
• W1979550833 hasPublicationYear "2008" @default.
• W1979550833 type Work @default.
• W1979550833 sameAs 1979550833 @default.
• W1979550833 citedByCount "38" @default.
• W1979550833 countsByYear W19795508332012 @default.
• W1979550833 countsByYear W19795508332013 @default.
• W1979550833 countsByYear W19795508332014 @default.
• W1979550833 countsByYear W19795508332015 @default.
• W1979550833 countsByYear W19795508332016 @default.
• W1979550833 countsByYear W19795508332017 @default.
• W1979550833 countsByYear W19795508332018 @default.
• W1979550833 countsByYear W19795508332019 @default.
• W1979550833 countsByYear W19795508332022 @default.
• W1979550833 crossrefType "journal-article" @default.
• W1979550833 hasAuthorship W1979550833A5012093987 @default.
• W1979550833 hasAuthorship W1979550833A5019865568 @default.
• W1979550833 hasAuthorship W1979550833A5033220805 @default.
• W1979550833 hasAuthorship W1979550833A5033658591 @default.
• W1979550833 hasAuthorship W1979550833A5038203474 @default.
• W1979550833 hasAuthorship W1979550833A5042943293 @default.
• W1979550833 hasAuthorship W1979550833A5046170398 @default.
• W1979550833 hasAuthorship W1979550833A5064118768 @default.
• W1979550833 hasAuthorship W1979550833A5070124449 @default.
• W1979550833 hasAuthorship W1979550833A5077833691 @default.
• W1979550833 hasConcept C111566952 @default.
• W1979550833 hasConcept C126322002 @default.
• W1979550833 hasConcept C134018914 @default.
• W1979550833 hasConcept C159110408 @default.
• W1979550833 hasConcept C164705383 @default.
• W1979550833 hasConcept C2777404818 @default.
• W1979550833 hasConcept C2777687718 @default.
• W1979550833 hasConcept C2778198053 @default.

• next